These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. STEAP1 is overexpressed in cancers: a promising therapeutic target. Moreaux J, Kassambara A, Hose D, Klein B. Biochem Biophys Res Commun; 2012 Dec 14; 429(3-4):148-55. PubMed ID: 23142226 [Abstract] [Full Text] [Related]
9. The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer. Duncan TJ, Watson NF, Al-Attar AH, Scholefield JH, Durrant LG. World J Surg Oncol; 2007 Mar 09; 5():31. PubMed ID: 17349047 [Abstract] [Full Text] [Related]
10. The Prognostic Value and Immunological Role of STEAP1 in Pan-Cancer: A Result of Data-Based Analysis. Zhao C, Xiong K, Ji Z, Liu F, Li X. Oxid Med Cell Longev; 2022 Mar 09; 2022():8297011. PubMed ID: 35313641 [Abstract] [Full Text] [Related]
11. Down-regulation of the microRNA processing enzyme Dicer is a prognostic factor in human colorectal cancer. Faggad A, Kasajima A, Weichert W, Stenzinger A, Elwali NE, Dietel M, Denkert C. Histopathology; 2012 Oct 09; 61(4):552-61. PubMed ID: 22716222 [Abstract] [Full Text] [Related]
12. STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score. Gomes IM, Arinto P, Lopes C, Santos CR, Maia CJ. Urol Oncol; 2014 Jan 09; 32(1):53.e23-9. PubMed ID: 24239460 [Abstract] [Full Text] [Related]
13. Six Transmembrane Epithelial Antigen 1 as a Prognostic Biomarker in Carcinomas: A Meta-Analysis. Zhao S, Chen H, Zhou Y, Wang Q, Liang X, Yang N, Yan L, Yang J. Front Biosci (Landmark Ed); 2023 Nov 06; 28(11):280. PubMed ID: 38062846 [Abstract] [Full Text] [Related]
14. Expression of CHD5 may serve as an independent biomarker of prognosis in colorectal cancer via immunohistochemical staining. Zhou Y, Qiu YE, Qin SL, Luo Y, Cui R, Qin J, Chen JJ, Yu MH, Zhong M, Shi XY. Int J Clin Exp Pathol; 2018 Nov 06; 11(5):2792-2798. PubMed ID: 31938397 [Abstract] [Full Text] [Related]
15. Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma. Hu L, Chen HY, Cai J, Yang GZ, Feng D, Zhai YX, Gong H, Qi CY, Zhang Y, Fu H, Cai QP, Gao CF. BMC Cancer; 2015 Dec 23; 15():1006. PubMed ID: 26699544 [Abstract] [Full Text] [Related]
16. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL, Sun J, Lai JJ, Jiang Y, Bai LH, Zhang LD. World J Gastroenterol; 2015 Jun 07; 21(21):6649-59. PubMed ID: 26074703 [Abstract] [Full Text] [Related]
17. Clinical significance of STEAP1 extracellular vesicles in prostate cancer. Khanna K, Salmond N, Lynn KS, Leong HS, Williams KC. Prostate Cancer Prostatic Dis; 2021 Sep 07; 24(3):802-811. PubMed ID: 33589770 [Abstract] [Full Text] [Related]
18. ATAD2 overexpression is associated with progression and prognosis in colorectal cancer. Hou M, Huang R, Song Y, Feng D, Jiang Y, Liu M. Jpn J Clin Oncol; 2016 Mar 07; 46(3):222-7. PubMed ID: 26819280 [Abstract] [Full Text] [Related]
19. Downregulation of DHRS9 expression in colorectal cancer tissues and its prognostic significance. Hu L, Chen HY, Han T, Yang GZ, Feng D, Qi CY, Gong H, Zhai YX, Cai QP, Gao CF. Tumour Biol; 2016 Jan 07; 37(1):837-45. PubMed ID: 26254099 [Abstract] [Full Text] [Related]
20. Prognostic significance of INF-induced transmembrane protein 1 in colorectal cancer. He J, Li J, Feng W, Chen L, Yang K. Int J Clin Exp Pathol; 2015 Jan 07; 8(12):16007-13. PubMed ID: 26884876 [Abstract] [Full Text] [Related] Page: [Next] [New Search]